These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37119578)

  • 1. Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood.
    Caraballo R; Reyes G; Semprino M; Chacón S; Galichio S; Adi J; Gallo A; Gamboni B; Cachia P; Fortini S; Espeche A
    Epilepsy Behav; 2023 Jun; 143():109220. PubMed ID: 37119578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of sulthiame as add-on therapy in children with myoclonic atonic epilepsy: A study of 35 patients.
    Caraballo RH; Reyes Valenzuela G; Fortini S; Espeche A; Gamboni B; Bautista C; Cachia P; Semprino M; Gallo A; Galicchio S
    Epilepsy Behav; 2022 Jun; 131(Pt A):108702. PubMed ID: 35526461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulthiame add-on therapy in children with focal epilepsies associated with encephalopathy related to electrical status epilepticus during slow sleep (ESES).
    Fejerman N; Caraballo R; Cersósimo R; Ferraro SM; Galicchio S; Amartino H
    Epilepsia; 2012 Jul; 53(7):1156-61. PubMed ID: 22509732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulthiame add-on therapy in children with Lennox-Gastaut syndrome: A study of 44 patients.
    Caraballo RH; Flesler S; Reyes Valenzuela G; Fortini S; Chacón S; Ross L; Noli D
    Seizure; 2018 Nov; 62():55-58. PubMed ID: 30286409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulthiame use in children with pharmacoresistant epilepsies: A retrospective study.
    Laliberté A; Berrahmoune S; Myers KA
    Epileptic Disord; 2024 Oct; 26(5):591-599. PubMed ID: 38818757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulthiame on seizure frequency and EEG in children with electrical status epilepticus during slow sleep.
    Topçu Y; Kılıç B; Tekin HG; Aydın K; Turanlı G
    Epilepsy Behav; 2021 Mar; 116():107793. PubMed ID: 33549940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures.
    Caraballo RH; Reyes Valenzuela G; Fortini S; Espeche A; Gamboni B; Silva W; Semprino M; Fasulo L; Chacón S; Gallo A; Galicchio S; Cachia P
    Epilepsy Behav; 2023 Jun; 143():109245. PubMed ID: 37182500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulthiame in childhood epilepsy.
    Ben-Zeev B; Watemberg N; Lerman P; Barash I; Brand N; Lerman-Sagie T
    Pediatr Int; 2004 Oct; 46(5):521-4. PubMed ID: 15491376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulthiame in refractory paediatric epilepsies: an experience of an 'old' antiepileptic drug in a tertiary paediatric neurology unit.
    Swiderska N; Hawcutt D; Eaton V; Stockton F; Kumar R; Kneen R; Appleton R
    Seizure; 2011 Dec; 20(10):805-8. PubMed ID: 21924927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulthiame add-on treatment in children with epileptic encephalopathy with status epilepticus: an efficacy analysis in etiologic subgroups.
    Kanmaz S; Simsek E; Serin HM; Yilmaz S; Aktan G; Tekgul H; Gokben S
    Neurol Sci; 2021 Jan; 42(1):183-191. PubMed ID: 32592101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulthiame treatment for patients with intractable epilepsy].
    Miyajima T; Kumada T; Kimura N; Mikuni T; Fujii T
    No To Hattatsu; 2009 Jan; 41(1):17-20. PubMed ID: 19172811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulthiame add-on therapy for epilepsy.
    Milburn-McNulty P; Powell G; Sills GJ; Marson AG
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009472. PubMed ID: 26510094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
    Rating D; Wolf C; Bast T
    Epilepsia; 2000 Oct; 41(10):1284-8. PubMed ID: 11051123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Igwe SC; Bragazzi NL
    Cochrane Database Syst Rev; 2020 May; 5(5):CD009887. PubMed ID: 32468572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with Sulthiame (Ospolot) in benign partial epilepsy of childhood and related syndromes: an open clinical and EEG study.
    Engler F; Maeder-Ingvar M; Roulet E; Deonna T
    Neuropediatrics; 2003 Apr; 34(2):105-9. PubMed ID: 12776234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulthiame add-on therapy for epilepsy.
    Milburn-McNulty P; Powell G; Sills GJ; Marson AG
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009472. PubMed ID: 23543577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized onset seizures with focal evolution (GOFE) - A unique seizure type in the setting of generalized epilepsy.
    Linane A; Lagrange AH; Fu C; Abou-Khalil B
    Epilepsy Behav; 2016 Jan; 54():20-9. PubMed ID: 26619379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy.
    da Silveira MR; Montenegro MA; Franzon RC; Guerreiro CA; Guerreiro MM
    Arq Neuropsiquiatr; 2006 Sep; 64(3B):705-10. PubMed ID: 17057871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide add-on therapy for focal epilepsy.
    Brigo F; Lattanzi S; Igwe SC; Behzadifar M; Bragazzi NL
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD001416. PubMed ID: 32715463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiripentol add-on therapy for focal refractory epilepsy.
    Brigo F; Igwe SC; Bragazzi NL
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009887. PubMed ID: 29747241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.